研究动态
Articles below are published ahead of final publication in an issue. Please cite articles in the following format: authors, (year), title, journal, DOI.

在美国,与人类乳头瘤病毒疫苗相关的保健歧视与变性和非二元性别年轻成年人之间存在关联。

Gender-Related Health Care Discrimination and Human Papillomavirus Vaccination Among Transgender and Nonbinary Young Adults in the United States.

发表日期:2023 Aug
作者: Madina Agénor, Elle Lett, Gabriel R Murchison, Ariella R Tabaac, Nadia Dowshen, Allegra R Gordon
来源: TRANSGENDER HEALTH

摘要:

尽管跨性别和非二元性别(TNB)人士也会感染人类乳头状瘤病毒(HPV),但目前很少有研究关注TNB人士接种HPV疫苗的情况。TNB个体在性别相关的医疗卫生中体验到高水平的歧视,这可能会影响他们接种HPV疫苗的积极性。本研究利用国家在线调查(N=716)的数据发现,跨性别女性和在出生时被指定为男性的非二元人士(AMAB)之间的性别相关医疗卫生歧视与HPV疫苗接种之间存在负相关(奥斯比比值[OR]=0.52;95%置信区间[CI]:0.29-0.93)。解决性别相关医疗卫生歧视问题可能有助于促进跨性别女性和非二元AMAB个体接种HPV疫苗,从而预防HPV相关的癌症。版权所有2023年,Mary Ann Liebert出版社。
Although transgender and nonbinary (TNB) people can acquire human papillomavirus (HPV), research examining HPV vaccination in these populations is scarce. TNB individuals experience high levels of gender-related health care discrimination, which may undermine HPV vaccine uptake. Using data from a national online survey (N=716), we found a negative association between gender-related health care discrimination and HPV vaccination among transgender women and nonbinary individuals who were assigned male at birth (AMAB; odds ratio [OR]=0.52; 95% confidence interval [CI]: 0.29-0.93). Addressing gender-related health care discrimination may facilitate HPV vaccination and help prevent HPV-related cancers among transgender women and nonbinary AMAB individuals.Copyright 2023, Mary Ann Liebert, Inc., publishers.